EHA Unplugged

AIDPATH – AI automated CAR T-cell manufacturing (with Dr Carmen Sanges)

Hematology Portraits: prof. Elizabeth Macintyre

Is low-risk MDS really low risk? (with Prof Uwe Platzbecker)

MRD Monitoring in MDS Patients (with Prof Arjan van de Loosdrecht)

Hematology Portraits: prof. Martin Dreyling

MDS Pathophysiology and the Role of Immune Dysfunction (with Dr Shahram Kordasti)

Mapping Rare Anemia Patient Data: RADeep (with Dr. María del Mar Mañú Pereira)

Hematology Portraits: prof. Antonio Almeida

Targeting the Immune System in MDS (featuring Prof Dominik Wolf)

Accelerating Clinical Trials with AI (with Dr Jan Moritz Middeke)

The Current Diagnostic Approach to MDS (with Dr Onima Chowdhury)

Hematology Portraits: Prof Brian Huntly

Mental Health in CLL

Patient Perspectives on Gene Therapy for Sickle Cell Disease and B-Thalassemia

Hematology Portraits: Prof Kostas Stamatopoulos

Management of High-risk MDS: Seeking Clarity for Classification and Treatment

Hematopoietic Stem Cells in Health, Aging and Malignancy: Focus on Metabolism (EHA2024)

Innovative Trial Design (EHA2024)

Hereditary Hematological Malignancies (HHMs): A New Era of Discovery in MDS and AML (EHA2024)

Hairy Cell Leukemia (HCL): Treatment of Relapsed Disease (EHA2024)

Iron Metabolism in Myelodysplastic Syndrome (MDS)

First-line Treatment of Primary Central Nervous System Lymphoma (PCNSL) (EHA2024)

Optimizing Global Care for Women with von Willebrand Disease (VWD) (EHA2024)

Iron and Infections: Back to the Future (EHA2024)

Long-term Outcomes in the Chemo-free era for Acute Promyelocytic Leukemia (EHA2024)

Thrombotic thrombocytopenic purpura (TTP): Is plasmapheresis history?

The Role of Artificial Intelligence in Hematology (featuring Dr Gregor Hormann)

From MDS to AML: Genetics of Progression (featuring Prof Lars Bullinger)

Screening for Sickle Cell Disease (with Prof David Rees)

The Environmental Impact on Hematology Practice (with Dr Stephen Hibbs)

Synthetic Patients: The Future of Clinical Trials?

Innovative tools for Disease Monitoring in Multiple Myeloma

Hematology Portraits: Prof Ivo Touw

Preventing Venous Thromboembolism (VTE) in Pregnant Women

Gene Therapy for Hemophilia

AI-driven Morphology in Hematology

Regulatory Landscape for CAR T-cell Therapy

Point-of-care CAR T-cell Manufacturing

Processes in CAR T-cell Therapy

CAR T-cell Therapy for Children with ALL​

CAR T-cell Therapy in AML: State of the Art

Ethical Considerations in CAR T-cell Therapy

CAR T-cell Therapy - A Patient's Perspective

Developments in CAR T-cell Therapy

Precision Medicine in Myelodysplastic Syndromes (MDS)

Diversity, Equity, and Inclusion in Hematology

Trends in CAR T-cell Therapy

Precision Medicine in Chronic Lymphocytic Leukemia (CLL)

Precision Medicine in Rare Hematological Diseases: Pyruvate Kinase Activators

Precision Medicine in Follicular Lymphoma